3U.S. Food and Drug Administration. Positron Emission Tomo- graphy (PET) : Questions and Answers about CGMP Regulations for PET Drugs[EB/OL]. (2009-12-9) [2012-4-30]. http:// www. fda. gov/Drugs/DevelopmentApprovalProeess/Manufactur- ing/ucm193476, htm.
5Ido T, Wan CN, Fowler JS, et al. Fluorination with F2 :conven- ient synthesis of 2-deoxy-2-fluoro-D-glucose [ J ] J Org Chem, 1977,42: 2341.
6Hamacher K, Coenen HH, Stocklin G. Efficient stereospecific synthesis of no-carrier-added 2- [ 18 F ] -fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution [ J ]. J Nucl Med, 1986,27:235.
7Fuchtner F, Steinbach J, Mading P. Basic previous term hydrol- ysis next term 2-[ Is F ] fluoro-1,3,4,6-tetra-O-acetyl-image-glu- cose in the preparation of 2-[ lS F 1 fluoro-2-deoxy-Image-glucose [ J]. Appl Radiat Isot, 1996,47:61.
8Shankar V, Lilja S, Brigitte V. A broad overview of positron e- mission tomography radiopharmaceuticals and clinical applica- tions: What is new? [J]. Semin Nucl Med,2011, 41: 246.
